Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SKY-0515 in Huntington's Disease
NCT07378644Phase 3Recruiting
- Sponsor
- Skyhawk Therapeutics
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Countries
- 10
01
Overview
A Phase 3 trial of SKY-0515 in Huntington's disease (HD), sponsored by Skyhawk Therapeutics. Started Jan 2026; status: recruiting.
02
Drugs
SKY-0515
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT07378644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378644.